Pol Boudes, MD in

Pol Boudes, MD

Login to view DISC.
Chief Medical Officer at Rectify Pharmaceuticals, Inc.
📍 Pennington, New Jersey, United States

Dr. Pol Boudes is the Chief Medical Officer at Rectify Pharmaceuticals, bringing over 30 years of experience as a senior physician in the pharma and biotech industry. Specializing in Endocrinology and Metabolic Diseases, he has held numerous CMO roles and contributed to multiple new drug registrations. He earned his M. D. from the University of Aix-Marseille.

His passion is centered on bringing innovative, life-changing therapies to patients. This is reflected in his interest in exploring novel medical technologies, including the use of AI to improve the reading of tissue biopsies, and new therapeutic approaches for chronic liver, kidney, and rare genetic diseases, which he follows closely.

He was part of the team at Roche that discovered protease inhibitors, drugs that completely transformed the lives of patients with HIV.

Read the full overview →
Experience
12 Years
Current Role
Chief Medical Officer
Job Level
Leadership
Location
Pennington, New Jersey, United States
Personality Overview

How Pol shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Pol cares about

Orphan Drug Development
His career has a strong emphasis on developing treatments for orphan, rare, and neglected diseases, including pioneering chaperone therapies for lysosomal storage disorders at Amicus Therapeutics.
Hepatobiliary Diseases
He has extensive experience leading clinical programs for liver diseases like NASH cirrhosis and primary biliary cholangitis at Galectin and CymaBay, and it remains a focus at Rectify.
+5 more topics Login to view topics
Career

Work history

8-2024
Chief Medical Officer
Rectify Pharmaceuticals, Inc.
1-2020
Board Member
Protalix Biotherapeutics (NYSE: PLX).
10-2013
Chief Medical Officer. International consultant Medical Affairs and Drug Development
Independent Chief Medical Officer
3-2020 - 8-2024
Chief Medical Officer
Galectin Therapeutics (NASDAQ: GALT)
4-2014 - 10-2019
Chief Medical Officer
Cymabay Therapeutics
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Doctor of Medicine (M.D.)
University of Aix-Marseille
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Pol. Free, 10 seconds.